Commentaires de nos clients
Votre panier
$0.00 (0 articles)
Search:
Perform search
Liste des catégories

Générique Cyclophosphamide - Cytoxan

News
Recherche par lettre:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Cytoxan
Cytoxan Générique est utilisé pour traiter certains types des cancers suivants: lymphome, myélome multiple, leucémie, mycose fongoïde, neuroblastome, cancer de l'ovaire, cancer de l'oeil et cancer du sein. Il est habituellement utilisé en combinaison avec d'autres médicaments. Il peut également être utilisé pour traiter certains problèmes de reins (syndrome néphrotique) chez les enfants.
$0.83
Bookmarks sociaux
Choose your language:



Remboursementgaranti
Achatsécurisé

Notre page de facturation est certifiée par:

Secure shopping certificates

Special Offer!

  • Cyclophosphamide drug makes the bone marrow more tumor-friendly - News-Medical.net

    Cyclophosphamide drug makes the bone marrow more tumor-friendlyNews-Medical.

  • Docs Need Primer on Long-Term Effects of Chemotherapy - Family Practice News Digital Network

    Family Practice News Digital NetworkDocs Need Primer on Long-Term Effects of ChemotherapyFamily Practice News Digital NetworkOnly 6% of primary care physicians were able to identify the main long-term effects (LEs) of doxorubicin (Adriamycin), paclitaxel (Taxol), oxaliplatin (Eloxatin), and cyclophosphamide (Cytoxan), compared with 65% of oncologists surveyed.

  • ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule ... - MarketWatch (press release)

    ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule .

  • Diffuse Large B-Cell Lymphoma: Current Treatment Approaches - Cancer Network

    Diffuse Large B-Cell Lymphoma: Current Treatment ApproachesCancer NetworkWhile a series of trials support R-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone, plus rituximab)-21 as the standard of care for all patients, DLBCL has substantial biological and clinical heterogeneity, leading to marked differences .

  • First cycle G-CSF for high-risk chemotherapy: Of Course! - Clinical Oncology News

    Clinical Oncology NewsFirst cycle G-CSF for high-risk chemotherapy: Of Course!Clinical Oncology NewsDawn Hershman, MD, of Columbia University in New York City, recently published an article in the Journal of Clinical Oncology noting the rapid uptake of dose-dense AC-Taxol (doxorubicin and cyclophosphamide followed by paclitaxel [ddAC-T]).

    Copyright © 2005-2010 Canadian Pharmacy Online Canada Pharmacy, Canadian Pharmacy.